Matthew Davidson

Matthew Davidson is a Quality Control Senior Scientist at Rentschler Biopharma SE since January 2022, with a solid background in quality control within the biopharmaceutical industry. Prior experience includes roles as Quality Control Scientist II and I at TCR² Therapeutics Inc. and as a Quality Control Validation Scientist and Analytical Scientist at TC BioPharm Limited. Matthew's expertise encompasses optimizing, performing, and validating T-cell assays to Good Manufacturing Practice (GMP) standards and conducting release testing for manufactured T cell products. Earlier career experiences include serving as a Research Assistant at the University of Glasgow, where ancient DNA extraction was conducted, and as a PhD Student at Cancer Research UK Beatson Institute, focusing on high throughput screening for driver genes in Head and Neck Squamous Cell Carcinoma. Matthew holds a Doctor of Philosophy (PhD) in Cancer Studies from the University of Glasgow and a Bachelor of Science (BSc) in Biomedical Sciences from Queen's University Belfast.